* Coccicid
* Digalactoside de la 4,4'-diamino-diphenyl-sulfone
* Eupatin II
* Galactosylamine, N,N'-(sulfonyldi-4,1-phenylene)bis-
* G.A.P.S.
* Reconan
* Solufone
* p,p'-Sulfonyldianiline-N,N'-digalactoside
* N,N'-(Sulfonyldi-p-phenylene)bis-galactosylamine
* N,N'-(Sulfonyldi-4,1-phenylene)bis(galactosylamine)
* Tibatin
*** CHEMICAL IDENTIFICATION ***
RTECS NUMBER : LW5920000
CHEMICAL NAME : Galactosylamine, N,N'-(sulfonyldi-p-phenylene)bis-
CAS REGISTRY NUMBER : 1329-37-9
LAST UPDATED : 198306
DATA ITEMS CITED : 2
MOLECULAR FORMULA : C24-H32-N2-O12-S
MOLECULAR WEIGHT : 572.64
COMPOUND DESCRIPTOR : Drug
SYNONYMS/TRADE NAMES :
* Coccicid
* Digalactoside de la 4,4'-diamino-diphenyl-sulfone
* Eupatin II
* Galactosylamine, N,N'-(sulfonyldi-4,1-phenylene)bis-
* G.A.P.S.
* Reconan
* Solufone
* p,p'-Sulfonyldianiline-N,N'-digalactoside
* N,N'-(Sulfonyldi-p-phenylene)bis-galactosylamine
* N,N'-(Sulfonyldi-4,1-phenylene)bis(galactosylamine)
* Tibatin
*** HEALTH HAZARD DATA ***
** ACUTE TOXICITY DATA **
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 10 gm/kg
TOXIC EFFECTS :
Peripheral Nerve and Sensation - flaccid paralysis without anesthesia
(usually neuromuscular blockage)
Behavioral - convulsions or effect on seizure threshold
Biochemical - Metabolism (Intermediary) - effect on inflammation or
mediation of inflammation
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans
Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4-
1898- Volume(issue)/page/year: 91,260,1952
TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 20 gm/kg
TOXIC EFFECTS :
Peripheral Nerve and Sensation - flaccid paralysis without anesthesia
(usually neuromuscular blockage)
Behavioral - convulsions or effect on seizure threshold
Lungs, Thorax, or Respiration - other changes
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans
Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4-
1898- Volume(issue)/page/year: 91,260,1952
*** END OF RECORD ***
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP